Basic Information
Neoplas Med GmbH is the only manufacturer in Europe to have obtained certification under the European Medical Device Regulation (MDR) for cold plasma products. Neoplas Med GmbH is exploring the fascinating possibilities of argon cold plasma jet therapy in clinical applications, with a commitment to effectively and sustainably improving the quality of life for patients with acute and chronic wounds. Argon plasma jet has antibacterial effects and promotes wound healing. The kINPen® MED is the world’s first cold plasma jet with argon. It enables effective and gentle wound treatment with the highest precision and consistent treatment quality—without any evidence of side effects or development of resistance, until possible wound closure.
Neoplas Med GmbH
Germany
15~50 people
January 01, 2009
contact@neoplas-med.eu

